Crossref
Research on the Mechanism of β-Sitosterol in Improving Polycystic Ovary Syndrome by Regulating CYP17A1/CYP19A1 Expression
Pharmacy Information · 2026 · 15 (02) · 84-93
DOI: 10.12677/pi.2026.152011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacy Information, 2026. Verfasst von 平洋 张. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
张, 平. (2026). Research on the Mechanism of β-Sitosterol in Improving Polycystic Ovary Syndrome by Regulating CYP17A1/CYP19A1 Expression. Pharmacy Information, 15(02), 84-93. https://doi.org/10.12677/pi.2026.152011
Vancouver
张 平. Research on the Mechanism of β-Sitosterol in Improving Polycystic Ovary Syndrome by Regulating CYP17A1/CYP19A1 Expression. Pharmacy Information. 2026;15(02):84-93. doi:10.12677/pi.2026.152011
BibTeX
@article{2026,
author = {张, 平洋},
title = {Research on the Mechanism of β-Sitosterol in Improving Polycystic Ovary Syndrome by Regulating CYP17A1/CYP19A1 Expression},
journal = {Pharmacy Information},
year = {2026},
volume = {15},
number = {02},
pages = {84--93},
doi = {10.12677/pi.2026.152011}
}
EUVIMED